Featured
California jury awarded a San Leandro resident $29 million after determining that Johnson & Johnson was aware that its talc-based baby powder product was contaminated and failed to warn the plaintiff. In August 2017, Ms. Leavitt, the plaintiff, was diagnosed with...
read more
Maryland Researchers have found that lymph nodes between the chest area and spine of malignant pleural mesothelioma patients are an exceedingly significant indicator of mesothelioma cancer prognosis. This discovery could radically alter the diagnosis of the accurate...
read more
The detailed investigatory report revealed that Johnson & Johnson, famous for its baby powder, was aware of the fact that their staple talc products were contaminated with carcinogenic substance, asbestos, but kept it from the public for decades. Talc and asbestos...
read more
Asbestos exposure in Johnson & Johnson talcum powder products can lead to mesothelioma and ovarian cancer, thus worrying the population using this type of product. There is an enormous number of talcum powder lawsuits against Johnson & Johnson due to its...
read more
Breath-based biomarkers for mesothelioma may prove encouraging to detect asbestos cancer early and could save lives. Since researchers are studying the results, they don't recommend the widespread usage of the test. Malignant pleural mesothelioma- MPM is...
read more
According to Italian research, an aggressive dose of advanced radiotherapy (radical Hemi-thoracic radiotherapy) can double the survival time of malignant pleural mesothelioma patients. Advanced and high dosage of radiotherapy at the affected location can increase the...
read more
CAR-T cell Immunotherapy and PD- 1 treatment showed Remarkable Antitumor Activity with no Toxic Effects, An Update on the Ongoing Clinical Trials. Ongoing clinical trials (May 2015 till April 2020) on CAR- T cell (chimeric antigen receptors) therapy combined with PD-I...
read more
According to the new Chinese research, soluble mesothelin-related peptide- SMRP is the best biomarker for the diagnosis of malignant mesothelioma in comparison with other biomarkers, regardless of its low sensitivity. Even though the sensitivity is low, but according...
read more
Lumicell- Experts are testing a new innovative imaging technology at Massachusetts General Hospital. The imaging technology can enhance the vision of residual metastatic cancerous cells, and thus enables the surgeons to remove most of the cancerous cells in the...
read more
About 70% of cancer patients suffer through insomnia at any point from cancer diagnosis to its treatment. This new study has shown that acupuncture and cognitive behavioral therapy (CBT) can be used as an efficient solution to tackle insomnia effectively in cancer...
read more